MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$135,568
Net Income
-$15,373,873
Net Profit Margin
-11340.34%
EPS
-$11.58
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
135,568
6,543,001
27,011
15,606
Cost of revenues
229,455
11,071
21,609
12,485
Gross profit
-93,887
6,531,930
5,402
3,121
Research and development
1,203,352
1,257,948
1,333,102
1,404,247
General and administrative
1,870,375
1,833,277
1,492,669
1,884,994
Legal expenses (recoveries), net
-
-
1,245,136*
6,006
Impairment of long-lived asset
-
-
375,000*
-
Legal expenses (recoveries), net
-1,325
6,850
-
-
Nonoperating loss
-
-
0*
0
Indirect tax expense
-
198,146
-
-
Total operating expenses
3,072,402
3,296,221
4,445,907
3,295,247
Operating income (loss)
-3,166,289
3,235,709
-4,440,505
-3,292,126
Interest expense
100,541
109,274
233,445
127,070
Change in fair value of investment
-
-
-68,355.5*
-
Change in fair value of investment and contingent liability, net
-
-
-
-966,284
Change in fair value of contingent liability
-
-
-263,956.5*
-
Gain on sale of put shares
-
-
282,464*
-182,146
Change in fair value of warrant liability
-2,443,335
667,343
-
-
Gain on extinguishment of liability
483,383
-
4,901,153*
-
Other income, net
7,551
8,888
13,964
13,290
Net loss before income taxes
-5,219,231
3,802,666
-
-
Income tax expense
-
330,186
-
-
Net gain
-5,219,231
3,472,480
719,232
-4,554,336
Equity dividend to investor
-
1,488,472
-
-
Net income (loss) attributable to common stockholders and holders of participating securities
-
1,984,008
-
-
Allocation of undistributed earnings to participating securities
-
728,299
-
-
Equity dividend to investor
10,154,642
-
4,185,194
0
Net gain attributable to common stockholders
-15,373,873
1,255,709
-3,465,962
-4,554,336
Basic EPS
-11.58
1.39
-1.652
-2.02
Diluted EPS
-11.58
1.39
-1.652
-2.02
Basic Average Shares
1,327,966
0
2,097,701*
2,260,068
Diluted Average Shares
1,327,966
904,312
2,097,701*
2,260,068
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net gain
attributable to common...
-$15,373,873
(-27.25%↓ Y/Y)
Equity dividend to
investor
$10,154,642
(0.01%↑ Y/Y)
Net gain
-$5,219,231
(-170.74%↓ Y/Y)
Net loss before
income taxes
-$5,219,231
Gain on
extinguishment of liability
$483,383
Other income, net
$7,551
(-53.88%↓ Y/Y)
Operating income (loss)
-$3,166,289
(8.60%↑ Y/Y)
Change in fair value of
warrant liability
-$2,443,335
Interest expense
$100,541
(-56.04%↓ Y/Y)
Total operating
expenses
$3,072,402
(-11.34%↓ Y/Y)
Gross profit
-$93,887
(-7266.95%↓ Y/Y)
Legal expenses
(recoveries), net
-$1,325
(-100.93%↓ Y/Y)
Revenues
$135,568
(1969.74%↑ Y/Y)
General and
administrative
$1,870,375
(-10.77%↓ Y/Y)
Research and development
$1,203,352
(-1.91%↓ Y/Y)
Cost of revenues
$229,455
(4278.91%↑ Y/Y)
Buy us a coffee
HCW Biologics Inc. (HCWB)
HCW Biologics Inc. (HCWB)